Aerosol of Enoximone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex, Biopharmaceutical Evidence for ARDS Applicability

• Egile Nagusiak: Chiara Migone (Egilea), Brunella Grassiri (Egilea), Lucia Vizzoni (Egilea), Angela Fabiano (Egilea), Baldassare Ferro (Egilea), Ylenia Zambito (Egilea), Anna Maria Piras (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2024-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Phosphodiesterase (PDE) inhibitors are gaining interest in the context of pulmonary pathologies. In particular, the PDE3 inhibitor enoximone (ENXM) has shown potential relative to the cure of asthma, chronic obstructive pulmonary disease (COPD), and acute respiratory distress syndrome (A...